A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN) - Join Clinical Trial NCTNCT06064890
How to Join This Clinical Trial - NCTNCT06064890
Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Frontotemporal Dementia, FTD, FTD-GRN, Dementia, Frontotemporal. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Frontotemporal Dementia, FTD, FTD-GRN, Dementia, Frontotemporal. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Frontotemporal Dementia, FTD, FTD-GRN, Dementia, Frontotemporal
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE1, PHASE2 - Safety and effectiveness study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06064890 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 16 locations. Find a study site near you:
Clinical Research Site
Columbus, Ohio 43210 - United States
Status: RECRUITING
Clinical Research Site
Nashville, Tennessee 37232 - United States
Status: RECRUITING
Clinical Research Site
Houston, Texas 77030 - United States
Status: RECRUITING
Clinical Research Site
Toronto, Ontario - Canada
Status: RECRUITING
Clinical Research Site
Amsterdam, - Netherlands
Status: RECRUITING
Clinical Research Site
Katowice, - Poland
Status: RECRUITING
Clinical Research Site
Katowice, - Poland
Status: RECRUITING
Clinical Research Site
Katowice, - Poland
Status: RECRUITING
Clinical Research Site
Szczecin, 70-111 - Poland
Status: RECRUITING
Clinical Research Site
Warsaw, - Poland
Status: RECRUITING
And 6 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE1, PHASE2 clinical trial for Frontotemporal Dementia, FTD, FTD-GRN, Dementia, Frontotemporal:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships